At the time of writing, BioAge Labs Inc [BIOA] stock is trading at $3.87, up 3.20%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The BIOA shares have gain 12.83% over the last week, with a monthly amount drifted -12.84%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Morgan Stanley downgraded its rating to Underweight on December 10, 2024, and dropped its price target to $5. On December 09, 2024, downgrade downgraded it’s rating to Hold and revised its price target to $7 on the stock. Citigroup downgraded its rating to a Neutral and decreased its price target to $7 on December 09, 2024. Morgan Stanley initiated its recommendation with a Overweight and recommended $40 as its price target on October 21, 2024. Jefferies started tracking with a Buy rating for this stock on October 21, 2024, and assigned it a price target of $42. In a note dated October 21, 2024, Citigroup initiated an Buy rating and provided a target price of $45 on this stock.
For the past year, the stock price of BioAge Labs Inc fluctuated between $2.88 and $26.62. Currently, Wall Street analysts expect the stock to reach $19 within the next 12 months. BioAge Labs Inc [NASDAQ: BIOA] shares were valued at $3.87 at the most recent close of the market. An investor can expect a potential return of 390.96% based on the average BIOA price forecast.
Analyzing the BIOA fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.2, Equity is -1.12 and Total Capital is -0.24. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.03.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 3.70 points at the first support level, and at 3.54 for the second support level. However, for the 1st resistance point, the stock is sitting at 3.99, and for the 2nd resistance point, it is at 4.12.
Ratios To Look Out For
It is important to note that BioAge Labs Inc [NASDAQ:BIOA] has a current ratio of 12.86. As well, the Quick Ratio is 12.86, while the Cash Ratio is 12.76.
Transactions by insiders
Recent insider trading involved Barton Shane, Principal Accounting Officer, that happened on Sep 27 ’24 when 2632.0 shares were purchased. Director, Pande Vijay Satyanand completed a deal on Oct 01 ’24 to buy 0.13 million shares. Meanwhile, Director Pande Vijay Satyanand bought 67096.0 shares on Oct 02 ’24.
